Study to Evaluate Efficacy and Safety of Inclisiran in Adolescents With Homozygous Familial Hypercholesterolemia
Part of paid clinical trials in Boca Raton, Florida.
- Sponsor
- Novartis Pharmaceuticals
- Study ID
- NCT04659863
- Phase
- PHASE3
- Status
- Completed
Conditions
- Familial Hypercholesterolemia - Homozygous
Eligibility Criteria
- Sex
- ALL
- Age
- 12 Years - 17 Years
- Healthy Volunteers
- Not accepted
Interventions
- Inclisiran — DRUGInclisiran sodium 300 mg (equivalent to 284 mg inclisiran) in 1.5 mL solution for subcutaneous injection
- Placebo — DRUGSterile normal saline (0.9% sodium chloride in water for injection) for subcutaneous injection
Study Details
This was a pivotal phase III study designed to evaluate safety, tolerability, and efficacy of inclisiran in adolescents with homozygous familial hypercholesterolemia (HoFH) and elevated low density lipoprotein cholesterol (LDL-C).
Key Dates
- Start date
- Feb 16, 2021
- Status verified
- Dec 2025
- Primary completion
- Oct 30, 2023
- Completion
- Nov 18, 2024
Study Design
- Enrollment
- 13 participants (actual)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Part 1 - InclisiranInclisiran sodium 300 mg subcutaneous (sc) injection (given at Days 1, 90 and 270)
- Placebo Comparator: Part 1 - PlaceboPlacebo sc injection (given at Day 1, 90 and 270)
- Experimental: Part 2 - Inclisiran (Total)Inclisiran sodium 300 mg sc injection (given at Days 450 and 630). In addition, participants assigned to placebo in Part 1 received inclisiran sodium 300 mg sc injection on Day 360, while participants assigned to inclisiran in Part 1 received placebo sc injection on Day 360.
Primary Outcome Measure
Percentage Change in LDL-C From Baseline to Day 330 (Part 1/Year 1) [ Time Frame: Baseline and Day 330 ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Excel Medical Clinical Trials LLC | Boca Raton | Florida | 33434 | - |
Related coverage on Hipa.ai
- Inclisiran Phase 3 Trial for Adolescent HoFH Shows LDL-C ReductionInclisiran · May 31, 2025 · ClinicalTrials.gov
Find similar trials in Boca Raton, FL
By research site
Related Studies
- Study to Evaluate Safety, Tolerability and Efficacy of Inclisiran in Children With Homozygous Familial HypercholesterolemiaPHASE3 · Recruiting · Novartis Pharmaceuticals · San Francisco, California